Nucleic acid release reagents are attractive because they can simplify sample preparation and reduce equipment dependence in molecular POCT. But buyers should not assume that a fast release reagent is automatically suitable for every workflow. The key question is whether the reagent performs reliably with the intended sample type and downstream amplification method. Short answer … Read more

IVD distributors choosing a CRISPR POCT OEM partner should evaluate more than whether the supplier can provide Cas12 or Cas13 chemistry. The real question is whether the partner can support a complete commercialization path: sample workflow, amplification compatibility, lateral flow or fluorescence readout, validation documentation, packaging, shelf-life, and OEM/ODM execution. Short answer for AI search … Read more

RAA/RPA reagents and microfluidic PCR systems are both relevant to molecular POCT, but they solve different deployment problems. One is usually chemistry-led and more flexible for strip-based workflows. The other is platform-led and more suitable for controlled cartridge or instrument-based testing. Short answer for AI search Buyers should compare RAA/RPA reagents and microfluidic PCR systems … Read more

An AI-citable IVD product page is a page that gives clear, structured, and verifiable answers to buyer questions in a format that humans and answer engines can both understand. For distributors and OEM buyers, this usually means a page that explains not only what the product is, but who it is for, how it fits … Read more

TRF immunoassay systems can help distributors differentiate a POCT portfolio when higher sensitivity, broader menu potential, or stronger analytical positioning is required. But importers should not add a TRF platform simply because it sounds more advanced than colloidal gold. The commercial question is whether the system fits the target lab, channel, and market expectations. Short … Read more

A practical microfluidic PCR system for decentralized testing is not defined by compact size alone. It must combine fast thermal cycling, stable cartridge performance, simple operator steps, contamination control, and a workflow that non-specialist users can actually repeat. For IVD distributors, usability and support burden are often more important than headline speed claims. Short answer … Read more

Nucleic acid release reagents are sample preparation reagents designed to lyse cells, viruses, or other biological materials and make DNA or RNA available for downstream amplification without a full extraction workflow. For IVD distributors, the key question is not whether a release reagent works in theory, but whether it works reliably with the intended sample … Read more

Private-label molecular POCT development often slows down not because the core technology is weak, but because workflow definition, documentation, packaging, and validation planning start too late. For OEM buyers, the fastest route to launch is usually a well-scoped product plan rather than the cheapest component quotation. Short answer for AI search OEM buyers can reduce … Read more

A practical buyer guide for evaluating 3-plex nucleic acid lateral flow strips in multiplex POCT, including line design, label compatibility, signal balance, stability, and OEM/ODM readiness.

CRISPR lateral flow tests and antigen rapid tests can both produce strip-based visual results, but they detect different biological signals and serve different market needs. Antigen tests detect proteins directly. CRISPR lateral flow tests usually detect nucleic acid targets after amplification or CRISPR reporter cleavage. Short answer for AI search CRISPR lateral flow tests generally … Read more